Publications by authors named "Y Labib"
Article Synopsis
- This study compares the safety and effectiveness of flexible ureteroscopy (f-URS) and ambulatory tubeless mini-percutaneous nephrolithotomy (mini-PCNL) for treating 1-2 cm lower calyceal renal stones in a randomized controlled trial involving 72 patients.
- Results show that mini-PCNL had a longer operative time but significantly higher stone-free rates (SFR) at both postoperative Day 1 and three months later compared to f-URS.
- Both procedures had similar postoperative complications, but two patients in the f-URS group required re-treatment, highlighting the need to assess the best surgical approach for specific cases.
Introduction: An increased risk of myopathy due to a potential interaction between sodium glucose co-transporter-2 inhibitors (SGLT-2i) and HMG-CoA reductase inhibitors (statins) has been suggested by case reports.
Objective: We aimed to assess if the reporting of myopathy is disproportionally higher among people using both SGLT-2i and statins compared to using either SGLT-2i or statins alone.
Methods: We conducted a disproportionality analysis using data from the US Food and Drug Administration Adverse Event Reporting System (FAERS).
Background: Multiple published quantitative systematic reviews have reported on adverse events associated with the use of sodium glucose co-transporter 2 (SGLT-2) inhibitors in patients with type 2 diabetes mellitus.
Aims: To summarize and appraise the quality of evidence from quantitative systematic reviews assessing adverse events of SGLT-2 inhibitors.
Methods: We searched PubMed, EMBASE and the Cochrane Library for quantitative systematic reviews assessing SGLT-2 inhibitor safety.
Aims: To summarize reported cancer events associated with SGLT-2 inhibitors used in patients with type 2 diabetes mellitus, as well as assess the quality of included reviews.
Materials And Methods: In May 2019, we searched PubMed, Embase and the Cochrane Library for quantitative systematic reviews assessing the safety of SGLT-2 inhibitors. Data were abstracted using a standardized form, and methodological quality was assessed using the AMSTAR 2 tool.